Doug Hampton 
LAS VEGAS, Oct. 6, 2023 /PRNewswire/ — Promising an immersive and uniquely transformative experience, Fit For Service’s ARKADIA: Festival Of A More Beautiful World returns to the mind-bending venue of AREA15 on November 2–5, 2023. The festival lineup features an extraordinary roster of talented artists, visionary speakers, and inspiring workshops, curated to kindle the imagination and … Read more
MIAMI, Oct. 5, 2023 /PRNewswire/ — Cano Health, Inc. (“Cano Health” or the “Company“) (NYSE: CANO) today announced that it has filed a preliminary proxy statement with the SEC regarding a special stockholders’ meeting to authorize Cano Health’s Board of Directors to effect a reverse stock split of the Company’s Class A and Class B common … Read more
ATLANTA, 5. Okt. 2023 /PRNewswire/ — Die US Food and Drug Administration (FDA) hat Lipogems eine weitere IDE-Studie (Investigational Device Exemption) für die Verwendung von Mikrofett zur Behandlung von Knie-Osteoarthritis (OA) erteilt. Die zweite IDE-Studie wird die Sicherheit und Wirksamkeit bei der Behandlung von Knie-OA im Vergleich zur Behandlung mit Kochsalzlösung untersuchen und 15-20 angesehene akademische … Read more
NEW YORK, Oct. 4, 2023 /PRNewswire/ — The light therapy market is expected to grow by USD 246.87 million from 2022 to 2027. In addition, the momentum of the market will progress at a CAGR of 4.72% during the forecast period, according to Technavio Research. The market has been segmented by end-user (commercial, domestic, and healthcare), type … Read more
NEW YORK, Oct. 3, 2023 /PRNewswire/ — Firmament, a provider of structured equity and debt capital solutions to small- and medium-sized enterprises, announced today an investment in Prime Providers (“Prime” or the “Company”), to support the Company’s acquisition of Right Choice In-Home Care (“Right Choice”). Prime is a home-based healthcare organization providing private duty nursing, … Read more
FAIRFIELD, N.J., 2 de octubre de 2023 /PRNewswire/ — Vela Diagnostics anunció hoy una colaboración de investigación con SRL Inc, una importante empresa japonesa de servicios de atención médica. Esta asociación tiene como objetivo facilitar la distribución de las soluciones de diagnóstico molecular de vanguardia de Vela Diagnostics en Japón. Establecida en 1970, SRL Inc … Read more
PEYNIER, France, 1er octobre 2023 /PRNewswire/ — La collaboration entre Leo Cancer Care et THERYQ réunit la vaste expertise des deux organisations pour créer une solution intégrée qui promet de révolutionner le traitement des tumeurs solides profondes. S’appuyant sur une technologie de pointe et une ingénierie de précision, cette collaboration vise à fournir aux radio-oncologues et … Read more
SHENZHEN, China, Sept. 30, 2023 /PRNewswire/ — The 59th Annual Meeting of the European Association for the Study of Diabetes (EASD) is set to take place from October 2nd to 6th, 2023, in Hamburg, Germany. Making its debut at this prestigious event, Shenzhen Sibionics Technology Co., Ltd. (hereinafter referred to as “SIBIONICS”) will unveil its flagship … Read more
TAIPEI, Taiwan, Sept. 30, 2023 /PRNewswire/ — Foresee Pharmaceuticals (TPEx: 6576), (“Foresee”) announced today that the company will present the clinical design of the FP-045 Phase 1/2 clinical Fanconi anemia clinical study (FuschiA study) currently being initiated, at the Fanconi Anemia Research Fund (FARF) 2023 Scientific Symposium taking place in Vancouver, BC, Canada from September … Read more
MIDDLETON, Wisc., Sept. 29, 2023 /PRNewswire/ — Leo Cancer Care’s revolutionary patient positioning system designed to deliver radiation therapy in a more ‘human way’ for cancer patients has taken a critical step towards 510(k) regulatory clearance. With the regulatory decision for the innovative system now pending, 510(k) clearance will mean the upright technology will have … Read more